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BACKGROUND: Despite the volume of knowledge and daily reports on pre-eclampsia, its pathogenesis 
is still yet to be ascertained. Oxidative stress (oxidant (free radical) in excess of antioxidant) injury is one 
of the recently suggested pathogenetic mechanisms. This study, however, was designed to determine 
second and third trimesters of plasma malondialdehyde (product of free radical attack on membrane 
lipid) and vitamins C and E in pre-eclamptic Nigerian women. 
SUBJECTS AND METHODS: A Total of 100 subjects, each for pre-eclamptic, apparently normal and 
non-pregnant women qualified for the study. Venous blood samples were taken in the second and third 
trimesters of pregnancy and at the point of contact for non-pregnant women. Variables were analyzed 
using SPSS version 16, taking level of significance to be 0.05. 
RESULTS: Plasma malondialdehyde in the third trimester of normal pregnancy (2.03±0.71µmol/l) was 
found to be significantly higher than the one in the second trimester (1.65±0.62µmol/l) (p<0.0001). For 
pre-eclamptic subjects, the malondialdehyde in the third trimester (3.13±0.61µmol/l) was also higher 
than the malondialdehyde in the second trimester (3.00±1.21µmol/l).The mean vitamin C values for 
subjects with normal pregnancy were similar in the second and third trimesters (38.25±19.66 vs. 





 trimesters (35.05±18.37 vs. 37.20±24.44µmol/l;p=0.175).Mean vitamin E values in the second 
and third trimesters were also similar for subjects with normal pregnancy (28.62±13.85 vs. 
28.50±13.35µmol/l;p=0.950). A similar finding was observed in pre-eclamptic subjects (25.09±12.79 vs. 
28.00±14.83µmol/l;p=0.067). 
CONCLUSION: There was an increased product of membrane lipid attack (malondialdehyde) with no 
change in plasma levels of vitamins C and E as pregnancy advances into the third trimester of both 
normal and pre-eclamptic pregnancies. Antioxidant vitamins may not be useful in stopping the 
progression of free radical attack on membrane lipid to control pre-eclampsia. 
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Pregnancy, though a physiological process, is 
associated with some complications especially 
during the first gestation. This has been linked 
with changes in body metabolism in which 
oxidative stress and accumulation of lipid 
peroxidation products are being implicated (1-5). 
Pre-eclampsia and eclampsia are among the 
most serious complications of pregnancy in 
Nigeria (6). Despite the volume of knowledge on 
pre-eclampsia and eclampsia, studies have 
continued on a daily basis to unravel the roles and 
contributions of different pathologic mechanisms 
implicated. One of the implicated aetiopathologic 
mechanisms is the role of oxidative stress as a 
result of free radical injury. Oxidative stress is a 
result of imbalance between oxidant and 
antioxidant in favor of the oxidant (7). Oxidants 
are produced normally in aerobic metabolism but 
could be elevated in some pathological conditions 
(8-9).    
Idogun et al
 
in 2008 (10) observed a low 
antioxidant capacity in Nigerian pregnant women 
in a study done in South- south Nigeria.  Guptal et 
al in 2009 (11) in their study established that pre-
eclampsia is associated with increased 
concentration of oxidative stress markers 
including lipid peroxidation product 
(malondialdehyde) and a reduction in antioxidant 
concentration. Endothelial dysfunction secondary 
to oxidative stress has been implicated as a major 
pathological pathway in the development of 
hypertensive disorders of pregnancy (HDP) (12). 
Reduced serum antioxidant vitamins A and E have 
been reported in pre-eclampsia (13).  Plasma 
malondialdehyde has also been observed to be 
lower in patients placed on vitamin C supplement 
(14). 
It is envisaged that increased free radical 
activity leading to oxidative stress arises from 
production of free radicals or deficiency in 
protective antioxidant system (12). Injury to the 
cell as a result of free radicals may be due to its 
attack on membrane polyunsaturated lipid which 
is one of the most susceptible parts of the cell 
membrane. There are reports that suggest that 
there are increased free radical activities in 
hypertensive disorders of pregnancy (HDP) (4-5, 
15-16).  
Despite the increased volume of knowledge on 
oxidative stress as a factor in explaining the 
pathogenesis of pre-eclampsia from various parts 
of the world, studies that compare plasma 
malondialdehyde (MDA), vitamins E and C in the 
course of pre-eclamptic pregnancy is scarce. This 
study was, therefore, designed to determine the 
changes in plasma levels of malondialdehyde 
(MDA) and vitamins E & C in pre-eclamptic 
subjects in Osogbo, Nigeria. 
 
 MATERIALS AND METHODS 
 
The study sites were pregnancy booking clinics of 
Ladoke Akintola University of Technology 
Teaching Hospital, Osogbo and Egbedore Local 
Government Health Centre, Awo, Osun State in 
Nigeria. 
This study was a longitudinal cohort 
prospective one conducted over a period of 9 
months between May 2011 and January, 2012. 
Sampling was simple random technique and each 
patient was followed up for a period of eight 
weeks. Patients at the time of recruitment were 
between 20 and 27 weeks of gestation.   
A total of 118 and 115 subjects were 
recruited for pre-eclamptic and apparently normal 
pregnant women respectively out of which 100 
(for each) were finally selected to be included in 
the study. The calculated sample size was 86.67 
taking the prevalence of 6% for pre-eclampsia in 
Nigerian was used based on reports from previous 
studies (18-19). All subjects selected from the 
booking clinic in their second trimester, from 20 
weeks and above, were followed up to their third 
trimester. All the selected subjects at first contact 
were all above 20 weeks of gestation. The criteria 
used to include pre-eclamptic women were 
elevated blood pressure of greater than 140/90 
mmHg taken on two consecutive recordings at 
interval of 4-6 hours occurring in previously 
normotensive women or a rise in baseline systolic 
and diastolic blood pressure of 30 and 15mmHg 
respectively. Pre-eclamptic subjects also had a 
minimum proteinuria of 300mg in 24 hours urine 
sample or 1+ in dipstick urinalysis. One hundred 
age-matched, apparently healthy nonpregnant 
women were also recruited from the general 
population as a control. Women with other 
complications of pregnancy such as gestational 
diabetes, multiple gestation and cancer coexisting 




with pregnancy were excluded from the study. All 
the recruited subjects were not on vitamins C and 
E supplements. However, pre-eclamptic subjects 
were still on their regular treatment for pre-
eclampsia. They were placed on Nifedipine or 
Aldomet and some low dose of aspirin was 
included in the treatment. 
Ethical clearance to carry out the study was 
obtained from the Ethical Committee of Ladoke 
Akintola University of Technology Teaching 
Hospital, Osogbo.  
About 10mls of venous blood was collected 
in the second and third trimesters of normal and 
pre-eclamptic pregnant groups into lithium 
heparin specimen bottle from antecubital fossa 
following aseptic procedure of venepuncture. 
Similarly, venous sample was taken from 
nonpregnant controls at the point of contact.  Each 
batch of samples was centrifuged at 3000g for 
5mins. Plasma was separated carefully into plain 
screw cap specimen bottles and these were kept at-
20
o
C before analysis. Plasma sample was used for 
MDA and vitamins C and E analysis. Vitamins C 
and E were assayed using the Waters 616 HPLC 
machine manufactured by the Waters Corporation, 
USA. HPLC reagent, Chromosystem HPLC kit 
manufactured by chromosystems Instruments & 
Chemicals, Munchen, Germany) was used. Plasma 
samples previously stored at -20°C were used; 
Plasma MDA was analyzed by method of Satoh et 
al (20). . Each of these biochemical parameters 
were run in a batch of 50 samples.  
Data were entered and analyzed using 
Statistical Package for the Social Sciences (SPSS) 
16.0.  Continuous variables: age, gestational age, 
systolic and diastolic blood pressure were 
analyzed using mean ± SD. Biochemical variables: 
urine protein, malondialdehyde, vitamins C and E 
were summarized using frequency and mean ± 
SD. Measures of associations within biochemical 
variables, malondialdehyde and vitamins C and E 
were carried out using t-test, analysis of variance 
(ANOVA) and Spearman Correlation Coefficient. 




There was no statistically significant change in the 
mean age of the study subjects (p=0.169); non- 
pregnant group (NonP)=27.3±5.3years; normal 
pregnancy group (NP)=28.9±6.6years; pre-
eclamptic pregnancy group (PE)=28.9±4.3 
years).The mean gestational age of pre-eclamptic 
subjects (24.3±5.8 weeks)  was similar with that of 
normal pregnant women (24.0±1.7 weeks) 
(p=0.681) . This is illustrated in table 1. 
 
Table 1: Age and Gestational Age Distribution of Subjects 
 
 Non – Pregnancy Normal pregnancy Pre-eclamptic pregnancy 
Mean Age (yr) 






As illustrated in tables 2 and 3, the highest levels 
of MDA were seen in the pre-eclamptic subjects 
(2.87±0.91 µmol/l) while the lowest levels were 
seen in the non-pregnant subjects (0.96±0.67 
µmol/l). In the second trimester, plasma 
malonaldehyde in pre-eclamptic subjects 
(3.00±1.21µmol/l) was found to be significantly 
higher than in non-pregnant group (0.96±0.67 
µmol/l); p< 0.05. Similarly, in the second 
trimester, plasma MDA level was observed to be 
higher in the pre-eclamptic pregnant 
group(3.00±1.21µmol/l) than in normal pregnant 
group (1.65±0.62 µmol/l). This difference was 
statistically significant at p<0.05. In the third 
trimester of pregnancy, similar findings were 
observed with significantly higher plasma levels 
of MDA observed in pre-eclamptic 
group(3.13±0.61 µmol/l) than that in normal 
pregnancy group(2.03±0.71 µmol/l);p<0.05. In the 
same vien, in the third trimester, there was higher 
plasma MDA observed in normal pregnant group 
(2.03±0.71 µmol/l) than in non-pregnant group 
(0.96±0.67 µmol/l). This difference was 
statistically significant (p<0.0001). Plasma MDA 
in the third trimester of normal pregnancy 
(2.03±0.71µmol/l) was found to be significantly 
higher than in the second trimester 
(1.65±0.62µmol/l)(p<0.0001). For pre-eclamptic 
subjects, the MDA in the third trimester 
(3.13±0.61µmol/l) was higher than in the second 
trimester (3.00±1.21µmol/l), but the difference 
was not statistically significant (p=0.312). 





Table 2: Variables among the Study Groups in the Second and Third Trimesters 
 
Variable  Group Mean Second Trimester Third Trimester p-Value 















































Vit C (µmol/l) NonP 41.00±23.24 41.00±23.24 41.00±23.24 1 
 NP 38.46±19.53 38.25±19.66 38.66±19.40 0.882 
 PE 37.13±21.41 35.05±18.37 37.20±24.44 0.175 
Vit E (µmol/l) NonP 30.24±14.09 30.24±14.09 30.24±14.09 1 
 NP 28.56±13.6 28.62±13.85 28.50±13.35 0.950 
 PE 26.90±13.81 25.09±12.79 28.00±14.83 0.067 
* Statistically significant (p<0.05) 
 
Table 3: Comparison of Malondialdehyde (Mda) (Mean ± SD) in the 2
nd
  and 3
rd
 Trimesters across Study Groups 
 
Variables Study group Mean (µmol/l) p-Value 
MDA in 2
nd
 Trimester NonP Vs NP  
NonP Vs PE 
NP Vs PE 
0.96±0.67 Vs 1.65±0.62 
0.96±0.67 Vs 3.00±1.21 






 Trimester NonP Vs NP 
NonP Vs PE 
NP Vs PE 
0.96±0.67 Vs 2.03±0.71 
0.96±0.67 Vs 1.73±0.61 




NP-Normal pregnant women, PE- Pre-eclamptic women, NonP-Non pregnant women, *Statistically significant 
(p<0.05)         
       
Group mean vitamin C levels were highest in non-
pregnant subjects (41.00±23.24µmol/l) and lowest 
in the pre-eclamptic subjects (37.13±21.41µmol/l) 
. In the second trimester, plasma vitamin C levels 
were observed to be lower in pre-eclamptic group 
(35.05±18.37µmol/l) than in normal pregnancy 
group (38.25±19.66 µmol/l) although the 
difference was not statistically significant 
(p=0.268). By the same token, in the second 
trimester, lower plasma vitamin C level was found 
in subjects with pre-eclampsia 
(35.05±18.37µmol/l) than in nonpregnant subjects 
(41.00±23.24µmol/l); this difference was 
statistically significant at p=0.045 has shown in 
table 4b below. Similar findings were observed in 
the third trimester, i.e.lower level of vitamin C 
was observed in pre-eclamptic subjects 
(37.20±24.44 µmol/l) when compared with normal 
pregnancy group (38.66±19.40). This difference 
was not statistically significant (p=0.863). 
Although not statistically significant (p=0.436), in 
the third trimester, lower plasma vitamin C was 
observed in patients with pre-eclampsia 
(37.20±24.44 µmol/l) than in nonpregnant group 
(41.00±23.24 µmol/l).The mean vitamin C level 
was also observed in the third trimester to be 
lower in normal pregnancy group (38.66±19.40 
µmol/l) when compared with nonpregnant 
subjects. This difference was not statistically 
significant (p=0.360). The mean vitamin C values 
for subjects with normal pregnancy were similar 
in second and third trimesters (38.25±19.66 Vs 




38.66±19.40;p=0.882). For subjects with pre-
eclampsia, the mean vitamin C values were also 
similar in the second and third trimesters 
(35.05±18.37 Vs 37.20±24.44µmol/l; p=0.175). 
This is as shown in table 4. 
 




 Trimesters across Study Groups 
 





NonP Vs NP 
NonP Vs PE 
NP Vs PE 
41.00±23.24 Vs 38.25±19.66 
41.00±23.24 Vs 35.05±18.37 








NonP Vs NP 
NonP Vs PE 
NP Vs PE 
41.00±23.24 Vs 38.66±19.40 
41.00±23.24 Vs 37.20±24.44 








NonP Vs NP 
NonP Vs PE 
NP Vs PE 
30.24±14.09 Vs 28.62±13.86 
30.24±14.09 Vs 25.09±12.79 








NonP Vs NP 
NonP Vs PE 
NP Vs PE 
30.24±14.09 Vs 28.50±13.35 
30.24±14.09 Vs 28.00±14.83 




NP-Normal pregnant women, PE- Pre-eclamptic women, NonP-Non pregnant women, *Statistically 
significant (p<0.05)     
 
As a group, mean plasma vitamin E levels were 
highest in the non–pregnant subjects 
(30.24±14.09µmol/l) and lowest in subjects with 
pre-eclampsia (26.90±13.81µmol/l). In the second 
trimester, mean plasma vitamin E was observed to 
be significantly lower in pre-eclamptic pregnancy 
(25.09±12.79µmol/l) in comparison with 
nonpregnant group (30.24±14.09µmol/l);p<0.005. 
Also, in the second trimester, lower value of 
vitamin E was found in pre-eclamptic group 
(25.09±12.79µmol/l) than in normal pregnancy 
group (28.62±13.86µmol/l); however, this 
difference was not statistically significant 
(p=0.068). The finding in the third trimester is not 
different-plasma lower levels of vitamin E were 
observed in pre-eclamptic group (25.09±12.79 
µmol/l) in comparison with normal pregnancy 
subjects (28.50±13.35µmol/l). This difference was 
not statistically significant (p=0.919). Similarly, in 
the third trimester, the plasma level of vitamin E 
was observed to be lower in pre-eclamptic group 
(25.09±12.79 µmol/l) than in the nonpregnant 
group (30.24±14.09µmol/l). However, this 
differece was not statistically significant (p=0.37). 
The values for the second and third trimesters 
were similar for subjects with normal pregnancy 
(28.62±13.85 Vs 28.50±13.35µmol/l;p=0.950). A 
similar finding was observed in pre-eclamptic 




The mean age of non-pregnant women was not 
statistically significant when compared with the 
other two study groups. In the present study, mean 
gestational age among the study groups falls 
within the same range. Obesity, ageing as well as 
increased gestational age have been found to 
influence some biochemical parameters like 
malondialdehyde (MDA) (21, 22). There were 
significant differences in systolic and diastolic 
blood pressure as well as urinary protein-they 
were higher in pre-eclamptic pregnant women 
than in the control groups, and this is expected as 
regards the basis of diagnosing pre-eclampsia. 
Systolic and diastolic blood pressure and urinary 
protein were significantly lowered in third 
trimester than in second trimester. This may 
indicate some level of improvement in the clinical 
condition of women with pre-eclampsia. 
In the course of the reaction of free radical 
with polyunsaturated membrane lipid, a product 
known as malondialdehyde is produced and this is 
currently being used as an index of free radical 
injury because it is more stable in the system. In 





our study, we observed an increase in plasma 
malondialdehyde level in pre-eclamptic women 
when compared with normal pregnant and non-
pregnant women in the second trimester of 
pregnancy. Similar findings were observed in the 
third trimester. Our finding is in agreement with 
similar studies which reported a significantly 
elevated level of malondialdehyde in both normal 
and pre-eclamptic pregnant women (22, 23). Some 
previous studies showed that malondialdehyde 
was found to be progressively increasing in the 
course of pregnancy and can be used to predict 
occurrence of pre-eclampsia in the third trimester 
of pregnancy (21, 24). As regards plasma levels of 
malonadildehyde in the second and third 
trimesters, significantly higher levels were 
observed in the third trimester of normal and pre-
eclamptic pregnant women. However, the value 
observed in the pre-eclamptic group was not 
statistically significant. This may be due to 
reduced disease burden as evidenced by lower 
blood pressure and urinary protein in the third 
trimester. Ilhan et al in 2002
 
reported similar 
findings (21). Vascular endothelial damage that 
results from free radical generation and possibly 
pre-eclampsia may have started from 20 weeks of 
pregnancy and may worsen with increasing 
demand of oxygen from maternal circulation by 
growing placenta. 
Vitamin C is an antioxidant which may be 
referred to as reducing agent. It reacts with 
superoxide and other lipid hydroperoxide radicals. 
This study observed plasma vitamin C level to be 
higher in women with apparently normal 
pregnancy than in those with pre-eclampsia in the 
second and third trimesters, which is not 
statistically significant. However, a significantly 
higher value in non-pregnant women than in pre-
eclamptic women was found in the second 
trimester but not in the third trimester. The 
pathological burden of pre-eclampsia and 
persistent physiology of normal pregnancy may 
have overwhelmed the availability of vitamin C 
which is being used to scavenge some free radicals 
being produced. It was observed by Luqman et al 
in Ilorin, Northern Central Nigeria, that women on 
vitamin C supplement tend to have reduced levels 
of free radical injury as shown by lower level of 
malondialdehyde than in a control group not on 
vitamin C supplement (14). This could be true 
because of inability of humans to synthesis 
vitamin C. In the present study, no significant 
changes in vitamin C levels were observed in both 
second and third trimesters of normal and pre-
eclamptic pregnancies. This is contrary to the 
work of Luqman et al
 
2008 (14) and Hassan et al
 
2006 (25) who observed decreasing level of 
vitamin C as pregnancy advances, though their 
sample size was small and dietary exposure may 
be different. However, our observation can be the 
result of increasing gestational age which is 
usually accompanied with increase tissue demand 
of nutrients and increase appetite.  
Antioxidant vitamins, especially vitamin E, 
are the most important chain breaking 
antioxidants, and they protect polyunsaturated 
fatty acid from peroxidation damage by donating 
hydrogen to the lipid peroxyl radical and vitamin 
E itself does not become a free radical as in the 
case with some antioxidant (26). This and its 
lipophilic nature vitamin E make it a good chain 
terminator in any lipophylic environment. In the 
present study, the plasma level of vitamin E in 
normal and pre-eclamptic pregnancies was 
reduced compared to non-pregnant group both in 
the second and third trimesters. However, this was 
not statistically significant except for the 
comparison between non-pregnant and pre-
eclamptic groups in the second trimester. On the 
other hand, lower value was found in some 
previous similar studies but with lower sample 
size than the present study (13, 25, 27).  
In conclusion, there was an increased plasma 
lipid peroxidation product (malondialdehyde) with 
no change in plasma levels of vitamins C and E as 
pregnancy advances into the third trimester of 
both normal and pre-eclamptic pregnancies. 
Therefore, studies focusing on another antioxidant 
probably antioxidant enzymes are necessary to 
identify the specific antioxidant to counteract lipid 
peroxidation (free radical injury). This may help in 
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